Abstract
Possible drug-interaction between elexacaftor-tezacaftor-ivacaftor and repaglinide in an adult with cystic fibrosis-related diabetes.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have